SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
化学名称: (8R,9S,10S,13S,14S)-10-(hydroxymethyl)-13-methyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-3H-cyclopenta[a]phenanthrene-3,17(2H)-dione
异名: 19-Hydroxyandrostendione
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
微笑: O=C1CC[C@@]2(CO)C(CC[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@@]3([H])CCC4=O)=C1
Dienogest Impurity 1 is chemically (8R,9S,10S,13S,14S)-10-(hydroxymethyl)-13-methyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-3H-cyclopenta[a]phenanthrene-3,17(2H)-dione. It is also known as 19-Hydroxyandrostendione . Dienogest Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Dienogest Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dienogest.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Polarographic Investigation of Dienogest
Melek Sirin Baymak, z Hayati Celik, Nurgul K. Bakırhan, Bengi Uslu, and Sibel A. Ozkan
Journal of The Electrochemical Society, 165 (10) G128-G132 (2018)
Rapid high performance liquid chromatography method development with high prediction accuracy, using 5 cm long narrow bore columns packed with sub-2 m particles and Design Space computer modeling
Szabolcs Feketea,∗, Jeno Fekete ˝ b, Imre Molnár c, Katalin Ganzler
Journal of Chromatography A, 1216 (2009) 7816–7823
A Novel Liquid Chromatography Tandem Mass Spectrometric Method for the Determination of Dienogest in Bulk and Commercial Formulation
Abel jacob george1 , s. t. narenderan1 , s. n. meyyanathan1*, b. babu1 and m. kalaivani
Journal of Pharmaceutical Research and Therapeutics 2020; Volume 1 (Issue 01); 31-34
Validated Stability Indicating RP-hplc Method for the Assay of Dienogest in Bulk and Tablet Dosage Form
Avilas Bhatta, Kailash Bansal, Prashant Hedau, Kumud Padhee, Prithipal Singh Kochhar
International Journal of Pharmaceutical Quality Assurance; 4(2); 20-26